Trading on Tuesday produced a patchwork of strong rallies and sharp pullbacks across market-cap segments. Semiconductor and industrial names featured prominently among the biggest gains, while pockets of the market - including some software and small-cap biotech and life-sciences stocks - saw steep falls.
Mega-cap movers (market cap $200 billion or higher)
- Intel Corp (INTC) +13.93%
- Micron Tech (MU); Trump administration looks to ease memory chip crunch with supply chain bloc - Nikkei +10.86%
- Lam Research Corp (LRCX) +7.0%
- Applied Matls Inc (AMAT) +5.45%
- Adv Micro Device (AMD); Zyphra launches AI platform powered by AMD GPUs +4.35%
- Avago Technologies (AVGO); Broadcom announces VMware Cloud Foundation 9.1 for AI workloads +3.72%
- Caterpillar (CAT) +2.84%
- Kla-tencor Corp (KLAC) +2.17%
- Palantir Technologies Inc (PLTR); Palantir reports 85% revenue growth in first quarter -6.91%
- Netflix, inc. (NFLX) -3.31%
The largest-cap segment featured pronounced upside among chipmakers and equipment suppliers, with Intel and Micron delivering double-digit advances while Palantir and Netflix traded lower.
Large-cap movers (market cap $10-$200 billion)
- Sterling Construc (STRL); Sterling Construction soars 19% on earnings beat, raised guidance +47.29%
- DigitalOcean Holdings (DOCN); DigitalOcean stock soars 16% on strong results, raised outlook +34.97%
- UL Solutions (ULS); UL Solutions stock rises 3% on strong earnings beat and margin outlook +14.0%
- Waters Corp (WAT); Waters Corporation stock rises 5% on strong earnings beat +12.49%
- SanDisk Corp-Exch (SNDK); Trump administration looks to ease memory chip crunch with supply chain bloc - Nikkei +12.51%
- Primoris Services (PRIM) +9.36%
- Rockwell Automat (ROK); Rockwell Automation stock surges 8% on strong earnings beat +9.34%
- Credo Technology Holding (CRDO) +9.09%
- Huntington Ingalls Industries Inc (HII); HII stock falls despite beating first quarter expectations -11.84%
- Shopify Inc (SHOP) -15.53%
Alongside singled-out earnings beats and raised guidance that propelled several names, the large-cap list also included heavy losses for a handful of companies despite positive reports.
Mid-cap movers (market cap $2-$10 billion)
- Bellring Brands LLC (BRBR); BellRing Brands tumbles on weak earnings and guidance -40.36%
- IPG Photonics Corp. (IPGP); IPG Photonics settles patent dispute with TRUMPF -28.4%
- Cytokinetics (CYTK); Cytokinetics to report ACACIA-HCM trial results Tuesday +16.69%
- Fastly Inc (FSLY) +16.55%
- Good Works Acquisition (CIFR); Cipher Digital reports Q1 revenue of $35M, secures $200M credit line +15.76%
- Fundrise Innovation Fund (VCX) +15.55%
- Ultra Clean Holdi (UCTT); UBS initiates Ultra Clean stock with buy rating on AI chip equipment demand +13.02%
- Edgewise Therapeutics (EWTX) +20.72%
- OSI Systems (OSIS) -16.45%
- Tessera Tech (ADEA); Adeia CEO Paul Davis to step down to focus on health -12.59%
This mid-cap set featured both large single-day declines tied to earnings or settlements and significant gains related to clinical or strategic company developments.
Small-cap movers (market cap $300 million - $2 billion)
- Embecta (EMBC); Embecta declares $0.01 quarterly dividend payable June 15 -56.81%
- CM Life Sciences (WGS); GeneDx plummets 46% as revenue guidance cut -49.73%
- EverQuote (EVER) +56.84%
- Signal Genetics (VRDN); Viridian’s elegrobart meets primary endpoint in chronic TED trial +32.5%
- POET Tech NAQ (POET) +31.08%
- INTW +28.05%
- Fortrea Holdings (FTRE) +26.82%
- Integra LifeScien (IART) +25.77%
- SNXX +24.7%
- GigCapital7 (GIG) -20.26%
Among small caps, several companies recorded outsized percentage moves, both up and down, often tied to corporate actions, trial news or dividend announcements.
What to watch within these moves
The day’s action underscores how sector-specific news - earnings beats, trial milestones, patent settlements and policy-related reports - continues to be a primary driver of intra-day volatility across market caps. Semiconductor-related headlines appeared particularly influential among the largest-cap stocks, while earnings and clinical-trial developments catalyzed many mid- and small-cap moves.